Deep endometriosis
Conditions
Interventions
The active intervention in this work consists of dividing an experimental group of 40 women into 2 subgroups. Experimental group 1: 20 women with deep and intestinal endometriosis who will be treated
Z30.8
Sponsors
Ache
Faculdade de Ciências Médicas da Santa Casa de São Paulo
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Women with clinical diagnosis of deep endometriosis; no hormone use for at least 3 months prior (wash out); who are patients of the Gynecology and Obstetrics Department of Santa Casa de Misericórdia de São Paulo, at the endometriosis clinic and who are on a waiting list for surgical treatment
Exclusion criteria
Exclusion criteria: Women using hormones; already operated on for endometriosis; with cognitive deficits
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinically assess quality of life in two groups of patients with deep endometriosis over a six-month period, using levonorgestrel iodine and progestin via the oral route, using the questionnaires: SF36 and EHP30 quality of life assessment. Being carried out before and after using the medication. | — |
Secondary
| Measure | Time frame |
|---|---|
| As a side effect, we could consider both the benefits and the side effects of the two medications: oral progestogen and levonogestrel implantation. The benefits would be the improvement in pain. And the side effects would be irregular bleeding and non-tolerability to the medication | — |
Countries
Brazil
Contacts
Public ContactBeatriz Porto
Faculdade de Ciências Médicas da Santa Casa de São Paulo
Outcome results
None listed